1. Hematology Division, Tokyo Metropolitan Cancer and Infectious diseases Center, Komagome Hospital, Tokyo, Japan;
2. Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan;
3. Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan;
4. Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan;
5. Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan;
6. Gastroenterology Division, Tokyo Metropolitan Cancer and Infectious diseases Center, Komagome Hospital, Tokyo, Japan;
7. Center for Integrative Medical Sciences, RIKEN, Kanagawa, Japan;
8. Graduate School of Environmental and Life Science, Okayama University, Okayama, Japan;
9. Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan;
10. Department of Hematology and Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan; and
11. Japan Agency for Medical Research and Development–Core Research for Evolutional Science and Technology, Tokyo, Japan